| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Cancer Research Campaign Laboratories, Department of Cancer Studies, University of Birmingham Medical School, Birmingham B15 2TJ, U.K.
Two monoclonal antibodies, E3cD8 and E3cA10, were generated to the EBNA 3c nuclear protein from the B95.8 isolate of Epstein—Barr virus (EBV). Both antibodies efficiently precipitate EBNA 3c from B95.8-transformed lymphoblastoid cell lines, and E3cA10 also detects EBNA 3c on Western blots. Whereas E3cD8 reacts with all 11 Type-1 isolates of EBV tested, and E3cA10 reacts with 14 of 17 Type-1 isolates, neither antibody detects the EBNA 3c protein encoded by Type-2 isolates. E3cD8 recognizes a peptide sequence (PA/PPQAPYQGY) in a repeat region of the B95.8 EBNA 3c coding sequence which is not present in the prototype Type-2 AG876 sequence. The E3cA10 antibody epitope has been mapped to the minimal five amino acid B95.8 peptide, WAPSV, which has an alanine to valine substitution in the AG876 virus isolate. This substitution was also found in three Type-1 EBV isolates that expressed EBNA 3c proteins not detected by E3cA10. In immunoprecipitation studies E3cA10 additionally coprecipitated the EBNA 2 protein from Type-1 isolates of EBV. The possibility of a direct interaction between EBNA 2 and EBNA 3c was ruled out by the demonstration that the antibody precipitated EBNA 2 from the Raji cell line which carries a virus with a deleted EBNA 3c gene. Since the WAPSV epitope identified in EBNA 3c is not present in EBNA 2, and no EBNA 2 linear peptide reactivity was detected in ELISA, it seems likely that E3cA10 recognizes a conformational epitope on EBNA 2. However, from the present data we cannot exclude the possibility that the antibody reacts with a cellular protein that physically associates with EBNA 2.
Present address: Department of Genetics, Yale University School of Medicine, New Haven, Connecticut 06510, U.S.A.
Present address: Department of Biochemistry, University of Leicester, Leicester LE1 7RH, U.K.
Received 4 October 1993;
accepted 11 November 1993.
This article has been cited by other articles:
|
|
 |
|
  L. Xing and E. Kieff Epstein-Barr Virus BHRF1 Micro- and Stable RNAs during Latency III and after Induction of Replication J. Virol., September 15, 2007; 81(18): 9967 - 9975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Chen, B. Zhao, E. Kieff, J. C. Aster, and F. Wang EBNA-3B- and EBNA-3C-Regulated Cellular Genes in Epstein-Barr Virus-Immortalized Lymphoblastoid Cell Lines. J. Virol., October 1, 2006; 80(20): 10139 - 10150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Yuan, E. Cahir-McFarland, B. Zhao, and E. Kieff Virus and Cell RNAs Expressed during Epstein-Barr Virus Replication J. Virol., March 1, 2006; 80(5): 2548 - 2565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Kelly, A. E. Milner, R. J. Tierney, D. S. G. Croom-Carter, M. Altmann, W. Hammerschmidt, A. I. Bell, and A. B. Rickinson Epstein-Barr Virus Nuclear Antigen 2 (EBNA2) Gene Deletion Is Consistently Linked with EBNA3A, -3B, and -3C Expression in Burkitt's Lymphoma Cells and with Increased Resistance to Apoptosis J. Virol., August 15, 2005; 79(16): 10709 - 10717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. West, H. M. Webb, A. J. Sinclair, and D. N. Woolfson Biophysical and Mutational Analysis of the Putative bZIP Domain of Epstein-Barr Virus EBNA 3C J. Virol., September 1, 2004; 78(17): 9431 - 9445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Knight, K. Lan, C. Subramanian, and E. S. Robertson Epstein-Barr Virus Nuclear Antigen 3C Recruits Histone Deacetylase Activity and Associates with the Corepressors mSin3A and NCoR in Human B-Cell Lines J. Virol., April 1, 2003; 77(7): 4261 - 4272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Cooper, E. Johannsen, S. Maruo, E. Cahir-McFarland, D. Illanes, D. Davidson, and E. Kieff EBNA3A Association with RBP-J{kappa} Down-Regulates c-myc and Epstein-Barr Virus-Transformed Lymphoblast Growth J. Virol., December 20, 2002; 77(2): 999 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Subramanian and E. S. Robertson The Metastatic Suppressor Nm23-H1 Interacts with EBNA3C at Sequences Located between the Glutamine- and Proline-Rich Domains and Can Cooperate in Activation of Transcription J. Virol., July 29, 2002; 76(17): 8702 - 8709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lin, E. Johannsen, E. Robertson, and E. Kieff Epstein-Barr Virus Nuclear Antigen 3C Putative Repression Domain Mediates Coactivation of the LMP1 Promoter with EBNA-2 J. Virol., January 1, 2002; 76(1): 232 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Lee, Y.-H. Hwang, S.-K. Lee, C. Subramanian, and E. S. Robertson An Epstein-Barr Virus Isolated from a Lymphoblastoid Cell Line Has a 16-Kilobase-Pair Deletion Which Includes gp350 and the Epstein-Barr Virus Nuclear Antigen 3A J. Virol., September 15, 2001; 75(18): 8556 - 8568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Cotter II and E. S. Robertson Modulation of Histone Acetyltransferase Activity through Interaction of Epstein-Barr Nuclear Antigen 3C with Prothymosin Alpha Mol. Cell. Biol., August 1, 2000; 20(15): 5722 - 5735. [Abstract] [Full Text]
|
|
|
|
|
|
A. J. Aguirre and E. S. Robertson Epstein-Barr Virus Recombinants from BC-1 and BC-2 Can Immortalize Human Primary B Lymphocytes with Different Levels of Efficiency and in the Absence of Coinfection by Kaposi's Sarcoma-Associated Herpesvirus J. Virol., January 1, 2000; 74(2): 735 - 743. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. T. Grundhoff, E. Kremmer, O. Tureci, A. Glieden, C. Gindorf, J. Atz, N. Mueller-Lantzsch, W. H. Schubach, and F. A. Grasser Characterization of DP103, a Novel DEAD Box Protein That Binds to the Epstein-Barr Virus Nuclear Proteins EBNA2 and EBNA3C J. Biol. Chem., July 2, 1999; 274(27): 19136 - 19144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Radkov, R. Touitou, A. Brehm, M. Rowe, M. West, T. Kouzarides, and M. J. Allday Epstein-Barr Virus Nuclear Antigen 3C Interacts with Histone Deacetylase To Repress Transcription J. Virol., July 1, 1999; 73(7): 5688 - 5697. [Abstract] [Full Text]
|
|
|
|
|
|
Q. Y. Yao, D. S. G. Croom-Carter, R. J. Tierney, G. Habeshaw, J. T. Wilde, F. G. H. Hill, C. Conlon, and A. B. Rickinson Epidemiology of Infection with Epstein-Barr Virus Types 1 and 2: Lessons from the Study of a T-Cell-Immunocompromised Hemophilic Cohort J. Virol., May 1, 1998; 72(5): 4352 - 4363. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
